viewEden Research PLC

Eden Research and Bayer Animal Health amend agreement

The UK group said there will be increased investment in the project, in part financed by Eden's successful March fundraise

Eden Research PLC -

Eden Research PLC (LON:EDEN) said its licence agreement with Bayer Animal Health has been amended as there will be increased investment in the project, in part financed by Eden's successful March fundraise.

The biopesticides group will also contribute its expertise in bio-active substances to the formulation development process.

The pair are working on an animal shampoo, a conditioner, a spray, and an ear flush using Eden’s encapsulation technology.

“The company has previously communicated that there have been some challenges relating to one important formulation,” investors were told in a statement.

“The amended agreement is designed to overcome these challenges and better meet Bayer's stringent product profile requirements through an expanded collaborative approach.”

Eden, a specialist in biopesticides and plastic-free encapsulation technology as well as animal health, said Bayer remains committed to the commercialisation of up to four products, subject to reformulation and testing.

The amended agreement also specifically references the intention of the two companies to enter into a supply agreement once development work has been successfully completed, the group added.

“If for any reason Bayer does not advance the project, both parties have agreed that all elements of the intellectual property and know-how will transfer to Eden, including formulations, clinical and marketing data, market research, business plans, the associated brands and trademarks, and other information relating to the project,” it explained.

Quick facts: Eden Research PLC

Price: 7.75 GBX

Market: AIM
Market Cap: £29.48 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research PLC named herein, including the promotion by the Company of Eden Research PLC in any Content on the Site, the Company receives...



Eden Research CEO hails new office and lab space for in-house research and...

Eden Research PLC's (LON:EDEN) Sean Smith speaks to Proactive London following the announcement they've moved office and opened up a new laboratory facility at Milton Park, a science cluster in Oxfordshire. Smith says the new facility will allow them to do more in-house, including formulation,...

1 week, 2 days ago

2 min read